Check out your Company Bowl for anonymous work chats.
World Arthritis Day 2024: Informed Choices, Better Outcomes On October 12, World Arthritis Day will raise awareness about the realities of living with rheumatic and musculoskeletal diseases (RMDs) and to advocate for better research, education, and patient support. On this day, we are all reminded of our collective responsibility to empower those affected by RMDs – including women and their families who lack concrete data and clear guidance about disease management and treatment, particularly during pregnancy and breastfeeding. Read more...
Delivering Medicines and Innovation: UCB & ClearPoint Neuro’s Partnership For UCB, innovation is not merely a buzzword; it's a relentless pursuit of excellence, improvement, and discovery. It encapsulates our drive to address unmet needs, to fill gaps, and to overcome weaknesses that persist in modern medicine. The work we do is about making tangible advancements that enhance the way we approach healthcare, offering new hope and possibilities to patients worldwide. This pursuit is deeply rooted in the belief that we can, indeed, build a better future. Read more...
People living with chronic diseases need holistic, sustainable solutions that go beyond treatment. They need care that seamlessly integrates into their lives and empowers them to live the lives they choose. At UCB, we’re committed to elevate the standard of care by going beyond the science. Harnessing cutting-edge technology, novel approaches, and close stakeholder collaboration allows us to address specific unmet needs, personalize treatment opportunities, and better support patients where they need it most. Learn more...
UCB is thrilled to share the latest progress on our groundbreaking gene therapy facility in Braine-l'Alleud, Wallonia, Belgium. The exterior of the facility is now complete, and we are currently moving forward with the “Fit Out” activities. The first equipment is delivered and already in place. This marks a significant milestone in our journey towards revolutionizing disease treatment through advanced gene therapy. Learn more...
Although the field of epilepsy research is well-established, we have only just begun to scratch the surface of our understanding of more complex epilepsies. We are entering a period of disruption, where new breakthroughs and the integration of innovative technologies into drug discovery and development show promise in transforming epilepsy care. One area is ‘molecular hallmarks’ – molecular signatures that contribute to the presentation of complex epilepsies. Learn more...
At UCB, we are on a remarkable journey. Our growth is just beginning, fueled by a clear focus on delivering differentiated medicines to people living with severe diseases. This commitment has translated into a portfolio of solutions, composed of our growth drivers and foundational medicines, delivering impressive results, and marking the strong beginning of a decade+ of growth. In this blog post, I will share our financial performance, key regulatory milestones, and outlook, illustrating how we are once again delivering on our commitments. Learn more...
On World AS Day 2024, UCB reaffirms its commitment to supporting people living with axial spondyloarthritis (axSpA). This year's theme, "Signs and Symptoms", highlights the importance of early recognition and diagnosis, to positively impact the lives of those affected by this chronic inflammatory disease through effective collaborations.
At UCB, we believe that providing opportunities for collaboration, discussion, and knowledge exchange for healthcare professionals can help make a real difference in improving the care and treatment of people living with serious neurological conditions, such as epilepsy. For this reason, we recently launched a new European meeting series for healthcare professionals, entitled: "Make the difference together".
Imagine a future where childhood diseases are a thing of the past, and every child grows up healthy. Let's work together to make that vision a reality. We are joining EFPIA - European Federation of Pharmaceutical Industries and Associations campaign for a world where kids can just be kids, free from illnesses.
At UCB, sustainability goes right to the heart of how we operate. Whether it’s expanding access to our solutions, innovating to solve societal health challenges, creating a working environment where our people can thrive, or reducing our impact on the planet. And we know that every action counts. This is why our colleagues are encouraged to actively engage in reducing their environmental footprint through numerous initiatives. One of these is the monthly Refill Market at UCB UK run by dedicated volunteers who sell eco-friendly cleaning and personal care products, encouraging colleagues to bring their containers or use our recycled ones to reduce packaging waste. Together, we’re united in our desire to help people living with severe diseases and contribute to a more inclusive and sustainable future for everyone. Learn more about our approach to Sustainability: https://lnkd.in/eBqwT7qX Learn more at UCB Careers: https://brnw.ch/21wIRus
